Search results
Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients
Author(s):
Charles Kennergren
Added:
3 years ago
Article
Author(s):
Suneet Mittal
,
Added:
3 years ago
Did you know that mortality is x3 times more likely once a cardiac infection takes hold? Therefore preventative solutions are vital.
In our latest Journal Club video, editorial board member, Dr Anil Saxena meets with the lead author of the WRAP-IT study, Dr Suneet Mittal.
Hear them discuss the outcomes of the randomised WRAP-IT global study which aimed to assess if the incremental use of an…
View more
Author(s):
Khaldoun G Tarakji
,
Christopher R Ellis
,
Pascal Defaye
,
et al
Added:
3 years ago
Over the last few decades an increasing body of evidence has supported the role of cardiovascular implantable electronic devices (CIEDs) including permanent pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT-D [with defibrillator] and CRT-P [without defibrillator]) in improving quality of life and survival.1 In addition, there has been a…
View more
Author(s):
Rikke Esberg Kirkfeldt
,
Jens Brock Johansen
,
Jens Cosedis Nielsen
Added:
3 years ago
Cardiac implantable electronic device (CIED) therapy is effective and safe. However, infections related to CIED treatment may have devastating consequences, causing significant morbidity, mortality and generating considerable healthcare costs.1–6 Temporal trends in CIED treatment indicate a disproportional increase in CIED infections relative to implantation rates.1,7,8 Reasons for this trend are…
View more
Author(s):
Cristian Podoleanu
,
Jean-Claude Deharo
Added:
3 years ago
The increasing use of cardiac implantable electronic devices (CIEDs) for management of cardiac conditions has over the last few years been associated with higher infection rates.1 Expanded CIED use alone cannot account for this rise,2–4 which involves both patient- and device-related factors. Indeed patients are tending to be older and presenting with co-morbidities, while devices are becoming…
View more
Author(s):
Adryan A Perez
,
Frank W Woo
,
Darren C Tsang
,
et al
Added:
3 years ago
The use of cardiovascular implantable electronic devices (CIEDs) has increased dramatically, with approximately 1.2–1.4 million CIEDs implanted annually worldwide.1 In the US alone, there are more patients with CIEDs than registered nurses.2,3 CIEDs use leads that connect a generator to cardiac tissue to treat patients with many conditions including symptomatic bradycardia, morbid tachycardia…
View more
Author(s):
Dhanunjaya Lakkireddy
Added:
1 year ago
TCT 2022 - Dr Dhanunjaya Lakkireddy (University of Kansas Hospital, Kansas City, US) joins us to discuss the safety and efficacy of the Amulet Left Atrial Appendage Occluder as suggested by the results of the AMULET-IDE Study.
AMULET-IDE was a prospective, multi-center study with a cohort of 1878 patients with non-valvular atrial fibrillation. Participants were randomized to receive either the…
View more
Author(s):
Philippe Charron
,
Eloisa Arbustini
,
Gisèle Bonne
Added:
3 years ago
Most mutations of the LMNA gene affect the heart, causing a dilated cardiomyopathy, ususally with conduction defect and ventricular arrhythmia, with or without skeletal muscle involvement. Although a relatively rare disease, cardiologists should be aware of laminopathies (diseases caused by LMNA gene mutations) because of the particularly aggressive course compared with most other…
View more
Author(s):
Chen Wei
,
Pierre Qian
,
Usha B Tedrow
,
et al
Added:
3 years ago
Ventricular tachycardia (VT) is a life-threatening sequela found in patients with cardiomyopathy. ICDs can terminate ventricular arrhythmias, but recurrent device shocks lead to reduced quality of life and are associated with higher mortality.1–5 Radiofrequency catheter ablation has emerged as an effective treatment for VT refractory to anti-arrhythmic therapy and has also been shown to reduce…
View more